Target intelligence / Profile preview

Shigella O-antigen Polysaccharide (O-antigen)

Target
O-antigen
Molecular classification
Polysaccharide, Lipopolysaccharide component, Antigen
01

Overview

The Shigella O-antigen polysaccharide is a highly variable surface carbohydrate essential for defining bacterial serotypes. Its structural diversity underpins both immune recognition/evasion strategies used by *Shigella* spp. It serves as an effective vaccine target due to its strong immunogenicity—antibodies directed at this molecule can protect against shigellosis. Genetic variation driven by environmental pressures—including bacteriophage predation—ensures ongoing diversity within populations.

Other names
Shigella O-polysaccharideShigella LPS O-antigenO-specific polysaccharideO-antigen polysaccharide
02

Mechanism of action

Antibody-mediated neutralization/opsonization, complement activation

03

Biological functions

Immune evasionSerotype determinationBacteriophage receptorAdhesionVirulence factorAntigen presentation
04

Disease associations

ShigellosisBacterial infectionDysentery
05

Safety considerations

Serotype variability challenges vaccine developmentPotential for immune evasion via O-antigen modificationLimited cross-protection between serotypes
06

Interacting drugs

Conjugate vaccines (O-antigen based)

1 more in the full profile.

07

Biomarkers

O-antigen serotype (for epidemiological studies)Anti-O-antigen antibody titer (vaccine efficacy)

Beyond the preview

Go deeper on Shigella O-antigen Polysaccharide (O-antigen).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shigella O-antigen Polysaccharide (O-antigen).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call